Search
Home › Stocks › AZN › News
1 / 10 Next
Regulatory
04 Apr 13:30 - Holding(s) in Company
03 Apr 10:00 - Director/PDMR Shareholding
02 Apr 15:00 - Total Voting Rights
01 Apr 18:00 - Astrazeneca
01 Apr 15:00 - Total Voting Rights
01 Apr 07:00 - Selumetinib gets Breakthrough Therapy Designation
29 Mar 17:15 - Results of Placing
29 Mar 07:00 - AZ and Daiichi Sankyo enter collaboration in novel
29 Mar 07:00 - Proposed placing of new ordinary shares
27 Mar 07:00 - Forxiga approved in Japan for type-1 diabetes
25 Mar 07:00 - Forxiga approved in Europe for type-1 diabetes
18 Mar 07:00 - US FDA grants saracatinib ODD for IPF
14 Mar 12:00 - Notice of AGM
12 Mar 12:00 - Director/PDMR Shareholding
06 Mar 07:00 - Filing of Form 20-F with SEC
05 Mar 11:00 - Annual Financial Report
04 Mar 16:04 - Holding(s) in Company
01 Mar 15:00 - Total Voting Rights
01 Mar 13:45 - Lynparza receives positive EU CHMP opinion
26 Feb 07:00 - Lynparza significantly delayed disease progression